載入...
Teriflunomide in relapsing multiple sclerosis: therapeutic utility
Teriflunomide is an oral, once-daily disease-modifying therapy (DMT) approved in the USA, Australia, and Argentina for the treatment of relapsing forms of multiple sclerosis (RMS). Teriflunomide reversibly limits the expansion of activated T and B cells associated with the inflammatory process purpo...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3752181/ https://ncbi.nlm.nih.gov/pubmed/23997924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622313492810 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|